RIS Program Agenda

HomeProgramRespiratory Innovation Summit ▶ RIS Program Agenda

Friday, May 13, 2022

6 - 6:30 p.m.

Networking Reception

6:30 - 7:30 p.m.

Dinner with Keynote Lecture

Saturday, May 14, 2022

7:30 – 8 a.m.

Attendee Check In, Poster Set-Up and Coffee

8 – 8:10 a.m.

Opening Comments and Sponsor Recognition

  • Lynn Schnapp, MD, ATSF – President, American Thoracic Society
    University of Wisconsin – Madison

8:10 – 8:25 a.m.

RIS Co-Chair Respiratory Report

  • Cecilia Gonzalo, MBA – Partner, Oberland Capital
  • Timothy Watkins, MD, MSc – Executive Director of Clinical Research, Respiratory Disease Lead, Gilead Sciences

8:25 - 9 a.m.

Executive Leadership Roundtable

  • Paul Burton, MD, PhD – Chief Medical Officer, Moderna 
  • Will Lewis – Chief Executive Officer, Insmed 
  • Other invites pending response 

9 - 9:35 a.m.

Fibrosis: Panel Discussion

Moderator:

  • Craig Conoscenti, MD, ATSF - Executive Director/Therapeutic Area Head Respiratory ILD Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Panelists:

  • Dr. Aryeh Fischer, MD
    Clinical Development Lead, Lung Fibrosis; Bristol Myers Squibb
  • Dr. John G. Goldin, MD
    Section Chief and Head of Radiology; UCLA Medical Center
  • Dr. Naftali Kaminski, MD, ATSF
    Section Chief and Head of Pulmonary and Critical Care; Yale School of Medicine
  • Dr. Elizabeth Volkmann, MD, MS
    Director, UCLA Scleroderma Program; Co-Director, UCLA Connective Tissue Disease-Related Interstitial Lung Disease Program; UCLA Medical Center
  • Timothy Watkins, MD, MSc – Executive Director of Clinical Research, Respiratory Disease Lead, Gilead Sciences 

9:35 – 10:05 a.m.

Fibrosis: Feature Companies Six companies will be selected for five-minute presentations. Click here to apply.

10:05 – 10:25 a.m.

Networking Break – Posters Available

10:25 – 11 a.m.

Inflammation and Immunology: Panel Discussion

Panelists:

  • Sean Agbor-Enoh, MD, PhD – Lasker Clinical Research Fellow, NIH Distinguished Scholar; Laboratory of Applied Precision Omics (APO); Division of Intramural Research, NHLBI
  • Anthony Coyle, PhD – President, Head of Research and Development, Repertoire Immune Medicines
  • Bethany Moore, PhD, ATSF – Chair, Department of Microbiology and Immunology; Pulmonary and Critical Care Medicine; University of Michigan
  • John Sundy, MD, PhD - Chief Medical Officer; Pandion Therapeutics

11 – 11:30 a.m.

Inflammation and Immunology: Feature Companies Six companies will be selected for five-minute presentations. Click here to apply.

Moderator:

  • Theodore F. Reiss, MD, MBE, ATSF – Executive Vice President and Chief Medical Officer; Repertoire Immune Medicines

11:30 a.m. – 12:10 p.m.

Regulatory Keynote

  • Robert J. Meyer, MD

1:10 – 1:45 p.m.

COVID-19: Panel Discussion

  • Roy M. Gulick – Weill Cornell Medical Center
  • Stacey Adam, PhD – Associate Vice President for Research Partnerships; Foundation of the NIH
  • Other invites pending

1:45 – 2:15 p.m.

COVID-19: Feature Companies Six companies will be selected for five-minute presentations. Click here to apply.

Moderator:

  • Colin F. Reisner, MF, ATSF – Chief Executive Officer; DevPro BioPharma

2:15 – 2:55 p.m.

Pharma Business Development Roundtable

Moderator:

  • Lyn Baranowski, MBA – Chief Operating Officer, Altavant

Panelists:

  • Amanda Mason, PhD – Director, Business Development, Amgen
  • Nicholas Mordwikin, PhD – Senior Director, Corporate Development - Head, Inflammation Therapeutic Area, Gilead Sciences
  • Ajay Narasimha, PhD – Senior Director, Global Business Development, Roche/Genentech
  • Kenny Simmen, PhD - VP, Scientific Innovation, Infectious Diseases and Vaccines, Janssen
  • Eric S. White, MD, MS,ATSF - Senior Clinical Program Lead - Interstitial Lung Diseases; Boehringer Ingelheim Pharmaceuticals, Inc.

2:55 – 3:15 p.m.

Networking Break – Posters Available

3:15 – 3:55 p.m.

Investor Panel Discussion

Panelists:

  • Steve Flaim, PhD – NHLBI; Flaim Partners Consulting
  • Heather Preston, MD – Founder and Managing Partner, Pivotal BioVentures
  • Stacy Seltzer – Partner, Aisling Capital
  • William Slattery – Partner, Deerfield
  • Amir Zamani, MD – Principle, Bain Capital Life Sciences

3:55 – 4 p.m.

Closing Remarks, Planning Committee and Sponsor Acknowledgements

  • Cecilia Gonzalo, MBA – Co-Chair
  • Tim Watkins, MD, MSc – Co-Chair

4 – 5 p.m.

Networking Cocktail Reception – Posters Available

 

 

****Last updated, 9 December 2021